R Ross MacLean1,2, Suzanne Spinola1,2, Ajay Manhapra2,3, Mehmet Sofuoglu1,2. 1. VA Connecticut Healthcare System, West Haven, Connecticut. 2. Yale University School of Medicine, New Haven, Connecticut. 3. VA Hampton Medical Center, Hampton, Virginia, USA.
Abstract
OBJECTIVE: To evaluate measurement and associations between pain severity and opioid craving in individuals with chronic pain on long-term opioid therapy and/or with opioid use disorder. STUDY DESIGN: . Systematic review of randomized controlled trials and observational studies. METHODS: . The PubMed, EMBASE, and PsycINFO databases were searched in October 2018. Eligible studies evaluated pain severity and opioid craving in individuals with chronic pain on long-term opioid therapy and/or with opioid use disorder. Two reviewers independently screened eligible studies, assessed risk of bias, and extracted data. RESULTS: Of 625 studies, 16 fulfilled the inclusion/exclusion criteria of this review and were grouped by diagnostic focus (i.e., chronic pain on long-term opioid therapy, opioid use disorder, or both). Methods of assessment varied considerably across studies, especially with respect to opioid craving in chronic pain populations. Mean levels of pain were at what is considered moderate to severe in individuals with chronic pain and/or opioid use disorder. There was a modest positive relationship between pain and opioid craving that was more pronounced in studies of individuals with opioid use disorder compared with those with chronic pain on long-term opioid therapy. CONCLUSIONS: Pain severity and opioid craving are likely related, but inconsistencies in measurement limit confidence. The overall quality of evidence is moderate, and careful consideration of how pain and craving are assessed in both chronic pain and opioid use disorder patients is warranted. 2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
OBJECTIVE: To evaluate measurement and associations between pain severity and opioid craving in individuals with chronic pain on long-term opioid therapy and/or with opioid use disorder. STUDY DESIGN: . Systematic review of randomized controlled trials and observational studies. METHODS: . The PubMed, EMBASE, and PsycINFO databases were searched in October 2018. Eligible studies evaluated pain severity and opioid craving in individuals with chronic pain on long-term opioid therapy and/or with opioid use disorder. Two reviewers independently screened eligible studies, assessed risk of bias, and extracted data. RESULTS: Of 625 studies, 16 fulfilled the inclusion/exclusion criteria of this review and were grouped by diagnostic focus (i.e., chronic pain on long-term opioid therapy, opioid use disorder, or both). Methods of assessment varied considerably across studies, especially with respect to opioid craving in chronic pain populations. Mean levels of pain were at what is considered moderate to severe in individuals with chronic pain and/or opioid use disorder. There was a modest positive relationship between pain and opioid craving that was more pronounced in studies of individuals with opioid use disorder compared with those with chronic pain on long-term opioid therapy. CONCLUSIONS:Pain severity and opioid craving are likely related, but inconsistencies in measurement limit confidence. The overall quality of evidence is moderate, and careful consideration of how pain and craving are assessed in both chronic pain and opioid use disorder patients is warranted. 2019 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
Entities:
Keywords:
Chronic Pain; Craving; Opioid Therapy; Opioid Use Disorder; Urges
Authors: Anna Parisi; Hannah Louise Landicho; Justin Hudak; Siri Leknes; Brett Froeliger; Eric L Garland Journal: Drug Alcohol Depend Date: 2022-02-24 Impact factor: 4.852
Authors: Kimberly A DiMeola; Jeff Haynes; Meredith Barone; Mark Beitel; Lynn M Madden; Christopher J Cutter; Anthony Raso; Marina Gaeta; Xiaoying Zheng; Declan T Barry Journal: J Addict Med Date: 2022 Mar-Apr 01 Impact factor: 3.702